({1-[(2-amino-6-ethoxy-9H-purin-9-yl)methyl]cyclopropyl}oxy)methylphosphonic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: ({1-[(2-amino-6-ethoxy-9H-purin-9-yl)methyl]cyclopropyl}oxy)methylphosphonic acid
• 英文别名: [1-[(2-Amino-6-ethoxy-purin-9-yl)methyl]cyclopropoxy]methylphosphonic acid；[1-[(2-amino-6-ethoxypurin-9-yl)methyl]cyclopropyl]oxymethylphosphonic acid
• 化学式: C₁₂H₁₈N₅O₅P
• 分子量: 343.279
• InChiKey: CSRBGMZKFZHFQX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.2
• 重原子数：
  23
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  146
• 氢给体数：
  3
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  [[[1-[[(甲基磺酰基)氧基]甲基]环丙基]氧基]甲基]膦酸二异丙酯 在 sodium hydride 、 三乙胺 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 8.0h， 生成 ({1-[(2-amino-6-ethoxy-9H-purin-9-yl)methyl]cyclopropyl}oxy)methylphosphonic acid
  参考文献：
  名称：

  [EN] NUCLEOSIDE PHOSPHONATE DERIVATIVES USEFUL IN THE TREATMENT OF HIV INFECTIONS
  [FR] DERIVES DE NUCLEOSIDE PHOSPHONATE UTILES DANS LE TRAITEMENT D'INFECTIONS VIH

  摘要：

  本发明涉及通过给予由式(I)表示的核苷酸膦酸衍生物来治疗HIV感染的方法。

  公开号：

  WO2005079812A1

文献信息

• [EN] NOVEL ACYCLIC NUCLEOSIDE PHOSPHONATE DERIVATIVES, SALTS THEREOF AND PROCESS FOR THE PREPARATION OF THE SAME<br/>[FR] NOUVEAUX DERIVES DE PHOSPHONATE NUCLEOSIDIQUE ACYCLIQUE, SELS DE CES DERNIERS ET PROCEDE DE PREPARATION DE CES DERNIERS
  申请人：LG CHEM INVESTMENT LTD

  公开号：WO2002057288A1

  公开（公告）日：2002-07-25

  The present invention relates to an acyclic nucleoside phosphonate derivative, which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof.

  本发明涉及一种无环核苷酸膦酸酯衍生物，其作为抗病毒剂（特别是对乙型肝炎病毒）有用，药学上可接受的盐，立体异构体以及其制备方法。
• Nucleoside phosphonate derivatives useful in the treatment of HIV infections
  申请人：Averett R. Devron

  公开号：US20060052346A1

  公开（公告）日：2006-03-09

  The present invention relates to a method of treating HIV infections by administering a nucleoside phosphonate derivative represented by formula (1).

  本发明涉及通过给予由式（1）表示的核苷酸膦酸衍生物治疗HIV感染的方法。
• Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
  申请人：——

  公开号：US20040063668A1

  公开（公告）日：2004-04-01

  The present invention relates to an acyclic nucleoside phosphonate derivative which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof.

  本发明涉及一种无环核苷酸膦酸酯衍生物，其可用作抗病毒剂（特别是对乙型肝炎病毒），药学上可接受的盐，立体异构体以及其制备方法。
• A Novel Class of Phosphonate Nucleosides. 9-[(1-Phosphonomethoxycyclopropyl)methyl]guanine as a Potent and Selective Anti-HBV Agent
  作者：Jong-Ryoo Choi、Dong-Gyu Cho、Kee Y. Roh、Jae-Taeg Hwang、Sinbyoung Ahn、Hyun S. Jang、Woo-Young Cho、Kyong W. Kim、Young-Gyo Cho、Jeongmin Kim、Yong-Zu Kim

  DOI：10.1021/jm0305265

  日期：2004.5.1

  9-[1-(Phosphonomethoxycyclopropyl)methyl]guanine (PMCG, 1), representative of a novel class of phosphonate nucleosides, blocks HBV replication with excellent potency (EC50 = 0.5 muM) in a primary culture of HepG2 2.2.15 cells. It exhibits no significant cytotoxicity in several human cell lines up to 1.0 mM. It does not inhibit replication of human immunodeficiency virus (HIV-1) or herpes simplex virus (HSV-1) at 30 muM. Many purine base analogues of 1 also exhibit inhibitory activity against HBV, but at 30 muM, pyrimidine analogues do not. 1 is 4 times more potent than 9- [2-(phosphonomethoxy)ethyl] adenine (PMEA), which was used as a positive control (EC50 = 2.0 muM). The characteristic cyclopropyl moiety at the 2'-position of 1 was prepared by titanium-mediated Kulinkovich cyclopropanation. 1 was modified to give the orally available drug candidate, PMCDG Dipivoxil (2). Compound 2 exhibited excellent efficacy when administered at 5 mg per kg per day in a study with woodchucks infected with woodchuck hepatitis B virus (WHBV). Drug candidate 2 has successfully completed phase I clinical trials and is currently undergoing phase II clinical studies for evaluation of efficacy.
• NOVEL ACYCLIC NUCLEOSIDE PHOSPHONATE DERIVATIVES, SALTS THEREOF AND PROCESS FOR THE PREPARATION OF THE SAME
  申请人：LG Chem Investment, Ltd.

  公开号：EP1358198A1

  公开（公告）日：2003-11-05